Abstract: This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Abstract: This disclosure relates to: (a) compounds and salts of formula (I), formula (II), formula (III), and formula (IV), that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Abstract: This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Abstract: This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Abstract: This disclosure relates to: (a) compounds and salts thereof that, inter alia, inhibit RSV infection and/or replication; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: A method and apparatus for providing a calling customer with arrangements for enhanced alerting of called numbers. A customer defines an alerting list which is entered by the telephone company and can be modified by the customer. When the customer dials a special number, the telephone stations associated with the telephone numbers on that customer's enhanced alerting list are alerted either in parallel (as in flexible alerting) or sequentially under the control of the caller. Advantageously, a customer can arrange to alert a predefined group of called numbers in response to dialing a special number.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) or other viruses are disclosed. This invention is also directed to compositions comprising such compounds, co-formulation or co-administration of such compounds with other anti-viral or therapeutic agents, processes and intermediates for the syntheses of such compounds, and methods of using such compounds for the treatment of HCV or other viral infections.

Abstract: A user is allowed to place a call to a target phone number upon receipt of one or more remembrance-promoted numbers and zero or more passwords, from the user, at an access phone number location. The one or more remembrance-promoted numbers comprise one or more of: an existing phone number employable by one or more users to place one or more direct calls to the user; and one or more numbers preselected by the user.

Abstract: A method of preserving or gracefully concluding wireless calls that are dropped when service is interrupted in a wireless communication system (100) (e.g., due to poor RF coverage). When a mobile unit (108) encounters a service interruption during a call, an announcement (208) is played inviting remaining participating unit(s) to hold. After a predetermined waiting time (210, 216), if service is not re-established to the mobile unit, the remaining unit(s) are invited (218) to leave a message (e.g., voice mail) for the mobile unit and connected (220) to a messaging system (126). After message(s) are concluded, the call is ended (226) or optionally, lo continued (206) if there is more than one remaining unit. If service is recovered before the waiting time expires, a service recovery announcement is provided (214) to the remaining unit(s) and the call continues (206).

Abstract: A method and apparatus for providing a calling customer with arrangements for enhanced alerting of called numbers. A customer defines an alerting list which is entered by the telephone company and can be modified by the customer. When the customer dials a special number, the telephone stations associated with the telephone numbers on that customer's enhanced alerting list are alerted either in parallel (as in flexible alerting) or sequentially under the control of the caller. Advantageously, a customer can arrange to alert a predefined group of called numbers in response to dialing a special number.

Abstract: The callback mobile subscriber station is capable of receiving a numeric page when the callback mobile subscriber station is located in an area where regular cellular telephone service is unavailable, by receiving data on a low frequency channel that is capable of service in the subscriber's present location. The subscriber can then initiate a callback call to the calling party when they are in an active service area by simply activating the callback function on the callback mobile subscriber station. The callback mobile subscriber station stores the calling party's telephone number and automatically places a call to that number when the callback feature is activated. Alternatively, the subscriber can use a land-line based telephone to return the missed incoming call, even though there is no cellular service in their present location.

Abstract: A system for identifying at least one selected mobile communication apparatus proximal with an identification locus includes: (a) a mobile communication base facility in communication with a plurality of mobile communication apparatuses that include the selected mobile communication apparatus; (b) at least one location-indicating device emitting a location-indicating code and is installed in each of the selected mobile communication apparatus; the location-indicating code relates a geographic location and an individual identification of a respective selected mobile communication device; and (c) at least one supported unit in communication with the mobile communication base facility. At least one of the mobile communication base facility and the supported unit have on-line access to an information store and a locator.